Latest Supply Chain Challenges News

Telix Pharmaceuticals has received a Complete Response Letter from the FDA for its TLX250-CDx diagnostic agent, citing manufacturing concerns. The company plans immediate remediation and maintains its 2025 revenue guidance.

Ambertech Limited reported a 6% increase in revenue to $101.2 million for FY25, yet net profit after tax fell sharply by 38% to $0.84 million amid inflationary pressures and increased costs. The company declared a fully franked final dividend and remains optimistic about FY26.

Elsight Limited has reported a remarkable 344% jump in first-half revenue to US$4.85 million, significantly narrowing its net loss and securing a substantial US$39 million capital raise to fuel growth.

Li-S Energy Limited reported a $6.41 million net loss for FY25 while making significant strides in commercialising its lithium-sulfur battery technology, including commissioning new production facilities and securing key strategic partnerships.

Breville Group Limited has announced a fully franked ordinary dividend of AUD 0.19 per share for the six months ending June 2025, signaling steady shareholder returns amid a competitive consumer market.

Sims Limited has announced a fully franked ordinary dividend of AUD 0.13 per share for the six months ending June 2025, signaling steady shareholder returns amid ongoing market conditions.

The a2 Milk Company reported a robust 21% rise in net profit for FY25, driven by strong growth in China and the USA, alongside a landmark full-year dividend declaration and major supply chain restructuring.

Nick Scali Limited reported a resilient FY25 with solid sales growth in Australia and New Zealand, while UK operations continue to improve margins despite ongoing losses. The company declared a fully franked dividend and outlined plans for further expansion.

Range International Limited reported a robust Q2 2025 with revenue surging 75% year-over-year and strong operational momentum despite supply challenges. The company’s strategic moves in Indonesia and the Philippines, alongside a favorable tax court ruling, set the stage for an ambitious growth trajectory.

Zimi Limited has completed production of its Smoke Connect safety range, progressed Matter Connect certification, and moved Senoa manufacturing to a new facility, while engaging investors for a capital raise.

Vital Metals’ latest Scoping Study for its Tardiff deposit in Canada reveals strong economic potential, underpinning an 11-year mine life with significant rare earth and niobium production. The company plans to advance to a Prefeasibility Study by the end of 2026, aiming to optimize recoveries and expand resources.

Radiopharm Theranostics reports significant progress in its oncology radiopharmaceutical pipeline, including FDA Fast Track designation and dose escalation approvals, supported by a solid cash runway through mid-2026.